AllerFund

Amulet specializes in detecting invisible threats within the global food system. It offers two core brands: Allergy Amulet, a consumer product that alerts users to potentially life-threatening allergens in foods, and Amulet Scientific, which equips businesses with tools to ensure food supply chain safety.

ATANIS Biotech specializes in clinical allergy research and diagnostic assay development. It operates a biotechnology company aiming to enhance the current standard of care for allergy diagnosis. The company offers a novel functional cell-based assay that simplifies allergy diagnosis and predicts treatment success, providing clients with a reliable tool for functional allergy screening.

IgGenix is a biotechnology company that develops an antibody-based therapeutic platform to treat food and other severe allergies. The platform re-engineers allergen-specific IgE antibodies into IgG antibodies to suppress the allergic cascade and alleviate or prevent allergic reactions. It identifies rare human B cells expressing allergen-binding antibodies and engineers them to endow immune-modulating activities derived from the IgG antibody class. Based in South San Francisco, California, the company aims to accelerate clinical responses to life-threatening allergies.

Alladapt Immunotherapeutics is a privately held biopharmaceutical company focused on developing prescription therapeutics for food allergy. Based in Menlo Park, California, it was founded in 2018. The company’s lead program, ADP101, is a broad-spectrum oral immunotherapy designed to mitigate, treat, and prevent reactions to foods by targeting single or multiple allergen proteins across common allergens.

IgGenix is a biotechnology company that develops an antibody-based therapeutic platform to treat food and other severe allergies. The platform re-engineers allergen-specific IgE antibodies into IgG antibodies to suppress the allergic cascade and alleviate or prevent allergic reactions. It identifies rare human B cells expressing allergen-binding antibodies and engineers them to endow immune-modulating activities derived from the IgG antibody class. Based in South San Francisco, California, the company aims to accelerate clinical responses to life-threatening allergies.

Bryn Pharma develops a needleless nasal device for administering emergency epinephrine in cases of anaphylaxis. Its bi-dose intranasal device offers a portable, easy-to-use alternative to traditional epinephrine auto-injectors.

Allergy Amulet Inc. is a Madison, Wisconsin-based company that specializes in the manufacture and sale of consumer food allergen sensors. Founded in 2016, the company has developed the Allergy Amulet, which is recognized as the world's smallest and fastest sensor for detecting common allergenic ingredients in food. This innovative device caters to a wide audience, including families, individuals, children, and businesses, allowing users to test food for allergens in seconds. Its sleek and portable design enables users to carry it conveniently on a keychain, necklace, or wristband, promoting safety and peace of mind for those affected by food allergies. With food allergies impacting approximately 32 million Americans and hundreds of millions globally, Allergy Amulet aims to enhance the quality of life for individuals with food allergies or intolerances.